Market Overview

Medtronic: Q2 Earnings Insights



Shares of Medtronic (NYSE:MDT) rose 0.2% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 22.14% over the past year to $1.02, which beat the estimate of $0.80.

Revenue of $7,647,000,000 decreased by 0.77% from the same period last year, which beat the estimate of $7,100,000,000.


Medtronic hasn't issued any earnings guidance for the time being.

Medtronic hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 24, 2020

Time: 08:00 AM

ET Webcast URL:

Recent Stock Performance

52-week high: $122.15

52-week low: $72.13

Price action over last quarter: Up 6.92%

Company Description

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.


Related Articles (MDT)

View Comments and Join the Discussion!

Posted-In: Earnings News